Sectra AB (publ) - SECT-B.ST

SECT-B.ST Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
SECT-B.ST	1.0	0.6	-10.4	-14.4	4.3	28.8	71.2	217.7	1065.0	735.2
S&P 500	0.9	-0.9	1.6	4.0	11.1	23.1	34.4	85.4	200.2	34258.4

Compare SECT-B.ST with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	SECT-B.ST
name	Sectra AB (publ)
price	248.15
changes percentage	0.9972
change	2.45
day low	245.5
day high	250
year high	301
year low	189.56
market cap	49069571092
price avg 50	271.735
price avg 200	255.97925
exchange	STO
volume	51831
avg volume	134585
open	245.5
previous close	245.7
eps	2.31
pe	107.42
earnings announcement	2025-03-14T07:15:00.000+0000
shares outstanding	197741572
timestamp	2025-01-28 16:29:50

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 58.3%

Overall Quarterly Financial Health: 47.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2963607000	2350752000	26.07
gross profit	557554000	2143516000	-73.99
gross profit ratio	0.19	0.91	-79.37
research and development expenses	39063000	304647000	-87.18
operating expenses	39063000	1687863000	-97.69
interest income	25991000	11849000	119.35
interest expense	3284000	2062000	59.26
ebitda	615060000	538553000	14.21
ebitdaratio	0.21	0.24	-14.92
operating income	518491000	455653000	13.79
operating income ratio	0.17	0.19	-9.74
net income	428388000	374957000	14.25
net income ratio	0.14	0.16	-9.38
eps	2.22	1.95	13.85

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,964 million in 2023 from 2,351 million in 2022 representing a change of 26.07%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 39 million in 2023 from 305 million in 2022 representing a change of -87.18%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 615 million in 2023 from 539 million in 2022 representing a change of 14.21%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 518 million in 2023 from 456 million in 2022 representing a change of 13.79%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 428 million in 2023 from 375 million in 2022 representing a change of 14.25%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.22 in 2023 from 2.22 in 2022 representing a change of 13.85%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 558 million in 2023 from 2,144 million in 2022 representing a change of -73.99%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 39 million in 2023 from 1,688 million in 2022 representing a change of -97.69%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	753500000	723836000	4.10
gross profit	652151000	633466000	2.95
gross profit ratio	0.87	0.88	-1.10
research and development expenses	0	11000000	-100.00
operating expenses	542584000	533651000	1.67
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	136906000	114963000	19.09
ebitdaratio	0.18	0.16	14.40
operating income	109567000	99815000	9.77
operating income ratio	0.15	0.14	5.45
net income	87759000	80401000	9.15
net income ratio	0.12	0.11	4.85
eps	0.46	0.42	9.52

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 754 million in 2024Q2 from 724 million in 2024Q1 representing a change of 4.1%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 652 million in 2024Q2 from 633 million in 2024Q1 representing a change of 2.95%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 137 million in 2024Q2 from 115 million in 2024Q1 representing a change of 19.09%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 88 million in 2024Q2 from 80 million in 2024Q1 representing a change of 9.15%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.46 in 2024Q2 from 0.46 in 2024Q1 representing a change of 9.52%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 11 million in 2024Q1 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 543 million in 2024Q2 from 534 million in 2024Q1 representing a change of 1.67%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 110 million in 2024Q2 from 100 million in 2024Q1 representing a change of 9.77%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	3210938000	2736667000	17.33
total liabilities	1641347000	1439998000	13.98
total equity	1569591000	1296669000	21.05
cash and cash equivalents	804640000	825242000	-2.50
short term investments	0	120000000	-100.00
long term investments	138443000	20000	692115.00
total current assets	2522148000	2208381000	14.21
total non current assets	688790000	528286000	30.38
total current liabilities	1588763000	1364641000	16.42
total non current liabilities	52584000	75357000	-30.22
common stock	38825000	38825000	0.00
retained earnings	1017850000	772927000	31.69
total debt	31788000	82262000	-61.36

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,211 million in 2023 from 2,737 million in 2022 representing a change of 17.33%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,570 million in 2023 from 1,297 million in 2022 representing a change of 21.05%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 2,522 million in 2023 from 2,208 million in 2022 representing a change of 14.21%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,018 million in 2023 from 773 million in 2022 representing a change of 31.69%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 32 million in 2023 from 82 million in 2022 representing a change of -61.36%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,641 million in 2023 from 1,440 million in 2022 representing a change of 13.98%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 805 million in 2023 from 825 million in 2022 representing a change of -2.5%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 120 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 1,589 million in 2023 from 1,365 million in 2022 representing a change of 16.42%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	3190365000	3171932000	0.58
total liabilities	1658130000	1517712000	9.25
total equity	1532235000	1654220000	-7.37
cash and cash equivalents	625776000	699355000	-10.52
short term investments	0	0	NaN
long term investments	0	165157000	-100.00
total current assets	2408703000	2437958000	-1.20
total non current assets	781662000	733974000	6.50
total current liabilities	1532839000	1444450000	6.12
total non current liabilities	125291000	73262000	71.02
common stock	0	38824179	-100.00
retained earnings	0	0	NaN
total debt	91909000	45884000	100.31

Overall Score of Quarterly Balance Sheet

0.12 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,190 million in 2024Q2 from 3,172 million in 2024Q1 representing a change of 0.58%. Suggesting a growth in asset holdings.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,658 million in 2024Q2 from 1,518 million in 2024Q1 representing a change of 9.25%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 1,532 million in 2024Q2 from 1,654 million in 2024Q1 representing a change of -7.37%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 626 million in 2024Q2 from 699 million in 2024Q1 representing a change of -10.52%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 2,409 million in 2024Q2 from 2,438 million in 2024Q1 representing a change of -1.2%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 1,533 million in 2024Q2 from 1,444 million in 2024Q1 representing a change of 6.12%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2024Q2 from 39 in 2024Q1 representing a change of -100.0%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 92 million in 2024Q2 from 46 million in 2024Q1 representing a change of 100.31%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-20602000	16467000	-225.11
operating cash flow	326326000	440488000	-25.92
free cash flow	75584000	347700000	-78.26
capital expenditure	-250742000	-92788000	-170.23
depreciation and amortization	98065000	91939000	6.66
deferred income tax	0	-61804000	100.00
stock based compensation	39043000	20938000	86.47
accounts payables	191609000	237752000	-19.41
inventory	-21541000	-12825000	-67.96
acquisitions net	0	0	NaN
investments in property plant and equipment	-250742000	-92788000	-170.23
net cash used for investing activites	-130741999	-212788000	38.56
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-211935000	-192662000	-10.00
dividends paid	0	-192662000	100.00
net cash used provided by financing activities	-222203000	-219289000	-1.33
cash at end of period	804640000	825242000	-2.50
accounts receivables	-408649000	-299595000	-36.40
cash at beginning of period	825242000	808775000	2.04

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -21 million in 2023 from 16 million in 2022 representing a change of -225.11%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 326 million in 2023 from 440 million in 2022 representing a change of -25.92%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 76 million in 2023 from 348 million in 2022 representing a change of -78.26%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -62 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 39 million in 2023 from 21 million in 2022 representing a change of 86.47%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -251 million in 2023 from -93 million in 2022 representing a change of -170.23%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 192 million in 2023 from 238 million in 2022 representing a change of -19.41%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -409 million in 2023 from -300 million in 2022 representing a change of -36.4%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 0 million in 2023 from -193 million in 2022 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	176067000	-56716000	410.44
free cash flow	148858000	-99799000	249.16
capital expenditure	-27209000	-43083000	36.85
depreciation and amortization	0	15148000	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-26698000	-28435000	6.11
accounts payables	0	-97146000	100.00
inventory	15309000	-11412000	234.15
acquisitions net	0	0	NaN
investments in property plant and equipment	-7823000	-30169000	74.07
net cash used for investing activites	-27209000	-43083000	36.85
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-211935000	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-217620000	-4336000	-4918.91
net change in cash	-73579000	-105285000	30.11
cash at end of period	625776000	699355000	-10.52
cash at beginning of period	699355000	804640000	-13.08

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -74 million in 2024Q2 from -105 million in 2024Q1 representing a change of 30.11%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 176 million in 2024Q2 from -57 million in 2024Q1 representing a change of 410.44%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 149 million in 2024Q2 from -100 million in 2024Q1 representing a change of 249.16%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q2 from 97 million in 2024Q1 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -27 million in 2024Q2 from -43 million in 2024Q1 representing a change of 36.85%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to -27 in 2024Q2 from -28 million in 2024Q1 representing a change of 6.11%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-04-30	2023-04-30	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	15.38	12.2	26.07
net income per share	2.22	1.95	14.25
operating cash flow per share	1.69	2.29	-25.92
free cash flow per share	0.39	1.8	-78.26
cash per share	4.18	4.91	-14.88
book value per share	8.15	6.73	21.05
tangible book value per share	6.79	5.5	23.36
shareholders equity per share	8.15	6.73	21.05
interest debt per share	0.18	0.44	-58.41
market cap	42068946223.15	30768448146.2	36.73
enterprise value	41296094223.15	30025468146.2	37.54
pe ratio	98.2	82.06	19.67
price to sales ratio	14.2	13.09	8.45
pocfratio	128.92	69.85	84.56
pfcf ratio	556.59	88.49	528.97
pb ratio	26.8	23.73	12.95
ptb ratio	26.8	23.73	12.95
ev to sales	13.93	12.77	9.10
enterprise value over ebitda	67.14	55.75	20.43
ev to operating cash flow	126.55	68.16	85.65
ev to free cash flow	546.36	86.35	532.69
earnings yield	0.01	0.01	-16.44
free cash flow yield	0.0	0.01	-84.10
debt to equity	0.02	0.06	-68.08
debt to assets	0.01	0.03	-67.07
net debt to ebitda	-1.26	-1.38	8.92
current ratio	1.59	1.62	-1.90
interest coverage	157.88	220.98	-28.55
income quality	0.76	0.97	-21.20
dividend yield	0	0.01	-100.00
payout ratio	0	0.51	-100.00
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.01	0.13	-89.83
intangibles to total assets	0.08	0.09	-5.65
capex to operating cash flow	0.77	0.21	264.77
capex to revenue	0.08	0.04	114.35
capex to depreciation	2.56	1.01	153.35
stock based compensation to revenue	0.01	0.01	47.91
graham number	20.19	17.17	17.60
roic	0.25	0.59	-58.41
return on tangible assets	0.15	0.15	-3.14
graham net net	1.8	1.92	-6.00
working capital	933385000	843740000	10.62
tangible asset value	1307261000	1059700000	23.36
net current asset value	880801000	768383000	14.63
invested capital	1457996000	1240170000	17.56
average receivables	1341498000	948406500	41.45
average payables	71748000	68964000	4.04
average inventory	36595500	30141000	21.41
days sales outstanding	191.48	175.19	9.29
days payables outstanding	11.54	118.75	-90.28
days of inventory on hand	5.55	64.46	-91.39
receivables turnover	1.91	2.08	-8.50
payables turnover	31.63	3.07	929.06
inventory turnover	65.76	5.66	1061.37
roe	0.27	0.29	-5.62
capex per share	1.3	0.48	170.23

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.27 on 2024-04-30 from 0.29 on 2023-04-30, representing a change of -5.62%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Current Ratio: Current Ratio decreased to 1.59 on 2024-04-30 from 1.62 on 2023-04-30, representing a change of -1.90%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 98.20 on 2024-04-30 from 82.06 on 2023-04-30, representing a change of 19.67%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.02 on 2024-04-30 from 0.06 on 2023-04-30, representing a change of -68.08%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-10-31 Q2	2024-07-31 Q1	Q/Q change %
SECT-B.ST
calendar year	2024	2024	NaN
revenue per share	3.91	3.76	4.10
net income per share	0.46	0.42	9.15
operating cash flow per share	0.91	-0.29	410.44
free cash flow per share	0.77	-0.52	249.16
cash per share	3.25	3.63	-10.52
book value per share	7.95	8.59	-7.37
tangible book value per share	6.55	7.22	-9.27
shareholders equity per share	7.95	8.59	-7.37
interest debt per share	0.48	0.24	100.31
market cap	54524899387	46714159382.94	16.72
enterprise value	53991032387	46060688382.94	17.22
pe ratio	155.33	145.25	6.93
price to sales ratio	72.36	64.54	12.13
pocfratio	309.68	-823.65	137.60
pfcf ratio	366.29	-468.08	178.25
pb ratio	35.59	28.24	26.01
ptb ratio	35.59	28.24	26.01
ev to sales	71.65	63.63	12.60
enterprise value over ebitda	394.37	400.66	-1.57
ev to operating cash flow	306.65	-812.13	137.76
ev to free cash flow	362.7	-461.53	178.59
earnings yield	0.0	0.0	-6.48
free cash flow yield	0.0	-0.0	227.79
debt to equity	0.06	0.03	116.25
debt to assets	0.03	0.01	99.15
net debt to ebitda	-3.9	-5.68	31.40
current ratio	1.57	1.69	-6.90
interest coverage	0	0	NaN
income quality	1.61	-0.71	327.80
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.02	-100.00
intangibles to total assets	0.08	0.08	2.04
capex to operating cash flow	0.15	-0.76	120.34
capex to revenue	0.04	0.06	-39.33
capex to depreciation	0	2.84	-100.00
stock based compensation to revenue	0	0	NaN
graham number	9.03	8.98	0.55
roic	0.05	0.05	13.85
return on tangible assets	0.03	0.03	8.72
graham net net	-5.36	-2.04	-162.38
working capital	875864000	993508000	-11.84
tangible asset value	1261651000	1390587001	-9.27
net current asset value	750573000	920246000	-18.44
invested capital	1487578000	1553694999	-4.26
average receivables	283268500	1072423500	-73.59
average payables	0	38035500	-100.00
average inventory	0	18295000	-100.00
days sales outstanding	0	70.44	-100.00
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	1.28	-100.00
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.06	0.05	17.84
capex per share	0.14	0.22	-36.85

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 155.33 on 2024-10-31 Q2 from 145.25 on 2024-07-31 Q1, representing a change of 6.93%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.57 on 2024-10-31 Q2 from 1.69 on 2024-07-31 Q1, representing a change of -6.90%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.06 on 2024-10-31 Q2 from 0.03 on 2024-07-31 Q1, representing a change of 116.25%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 56.56 which is lower than current price 248.15, indicates the company may be overvalued.